Nordea Investment Management Boosts Stake in HCA Healthcare

Institutional investor increases ownership in major healthcare provider

Mar. 22, 2026 at 10:07am

Nordea Investment Management AB, a major institutional investor, has increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 11.2% in the fourth quarter, according to a recent 13F filing with the Securities & Exchange Commission. Nordea now owns approximately 1.08 million shares of HCA Healthcare, worth over $507 million, making it one of the company's largest shareholders.

Why it matters

HCA Healthcare is one of the largest for-profit hospital operators in the United States, with a network of acute care hospitals, surgical centers, and outpatient clinics. Nordea's increased investment signals confidence in HCA's long-term growth prospects and the overall strength of the healthcare sector.

The details

According to the 13F filing, Nordea Investment Management purchased an additional 108,849 shares of HCA Healthcare during the fourth quarter, bringing its total ownership to approximately 1,084,590 shares. This represents about 0.48% of HCA Healthcare's outstanding stock. The increased investment comes as HCA Healthcare has seen its share price rise over the past year, driven by strong financial performance and growth in its core business lines.

  • Nordea Investment Management increased its stake in HCA Healthcare during the fourth quarter of 2025.

The players

Nordea Investment Management AB

A major European asset management firm that oversees over $500 billion in client assets.

HCA Healthcare, Inc.

A for-profit operator of healthcare facilities headquartered in Nashville, Tennessee, with a network of hospitals, surgical centers, and outpatient clinics across the United States.

Got photos? Submit your photos here. ›

The takeaway

Nordea's increased investment in HCA Healthcare reflects the firm's confidence in the healthcare provider's long-term growth potential. As one of the largest hospital operators in the U.S., HCA Healthcare's performance is seen as a bellwether for the broader healthcare industry.